Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 3Completed 3Withdrawn 1Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 9Lymphoma, Follicular 5Recurrence 4Lymphoma, Mantle-Cell 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma, B-Cell, Marginal Zone 4Leukemia 4Lymphoma, Non-Hodgkin 3Multiple Myeloma 2Lymphoma 2Hematologic Neoplasms 2Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms, Plasma Cell 1Lymphoma, B-Cell 1Leukemia, Plasma Cell 1Infectious Mononucleosis 1

Interventions

Melphalan 5Dexamethasone 4Bortezomib 3Arsenic Trioxide 3fludarabine phosphate 2Vorinostat 2Stem Cell Transplantation 2Peripheral Blood Stem Cell Transplantation 2Lenalidomide 2Drug Therapy 2Busulfan 2Ascorbic Acid 2ogalvibart 1ethanolamine oleate 1daratumumab 1crexavibart 1carfilzomib 1Zoledronic Acid 1Trimethoprim, Sulfamethoxazole Drug Combination 1Trimethoprim 1Therapeutics 1Thalidomide 1Tacrolimus 1Surveys and Questionnaires 1Sulfamethoxazole 1Sodium Chloride 1Simvastatin 1Saline Solution, Hypertonic 1Saline Solution 1Rituximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Neoplasms, Plasma Cell × Bendamustine Hydrochloride × Clear all
NCT01332617 2017-12-29

Phase II Study of Simvastatin for Relapsed/Refractory Myeloma

University of Louisville

Phase 2 Withdrawn
Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡